PMC5706971_01
Profile of serum testosterone over time since initiation of therapy, with first presentation at 6 months.
ioph-41-06-1316744-g001.jpg
PMC5706971_01_ioph-41-06-1316744-g001.jpg
F0001
He had started testosterone injections (250 mg 3-monthly) just prior to symptom onset (Figure 1). The patient decided to continue testosterone injections; the testosterone levels remained elevated (Figure 1) and his weight remains stable.
Composite figure showing colour fundus photographs of the papilloedema affecting the optic nerve head (OHN) of the right (A) and left (C) eyes. Optical coherence tomography (OCT) SPECTRALIS HRA+OCT (Heidelberg Engineering, Heidelberg, Germany), infrared (IR) images of the ONH, and volume cross-sectional images and the elevated height through the centre of the ONH of the right (E) and left (F) eyes. OCT IR disc volume reconstructions for right (B) and left (D) eyes.
ioph-41-06-1316744-g002.jpg
PMC5706971_01_ioph-41-06-1316744-g002.jpg
F0002
Spectral-domain optical coherence tomography was performed (Figure 2), and the overall maximum retinal nerve fibre layer (RNFL) height was 1226 mum for the left eye and 1218 mum for the right eye.